HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The CD40/CD40L axis in glioma progression and therapy.

AuthorsPaul R Walker, Denis Migliorini
JournalNeuro-oncology (Neuro Oncol) Vol. 17 Issue 11 Pg. 1428-30 (Nov 2015) ISSN: 1523-5866 [Electronic] England
PMID26206773 (Publication Type: Editorial)
Chemical References
  • CD40 Antigens
  • CD40 Ligand
Topics
  • Brain Neoplasms (metabolism, pathology, therapy)
  • CD40 Antigens (metabolism)
  • CD40 Ligand (metabolism)
  • Disease Progression
  • Glioma (metabolism, pathology, therapy)
  • Humans

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: